rapporteur Sabine Klepsch
3 IP cases indexed. Covers patent matters.
Cases Presided Over
3 cases indexed | Page 1 of 1
Alexion Pharmaceuticals, Inc. v.Samsung Bioepis NL B.V.
This UPC cost decision addressed the financial claims following a preliminary measures application concerning the pharmaceutical product Epysqli®. The court meticulously reviewed the claimed costs, distinguishing between reasonable expert fees and disproportionate legal representation expenses. While recognizing the necessity of certain travel and expert costs, the court struck down excessive charges from UK solicitors that did not demonstrate efficiency in the proceedings.
Alexion Pharmaceuticals, Inc. v.Samsung Bioepis NL B.V.
This UPC decision addressed a cost claim filed by Samsung Bioepis against Alexion Pharmaceuticals following the dismissal and rejection of provisional measures proceedings. The court found that while the overall application was admissible, several elements of the claimed costs were unreasonable or unsupported by evidence. Key adjustments included limiting travel accommodation reimbursement based on the actual arrival time at the hearing location.
Roche Diabetes Care GmbH v.Tandem Diabetes Care, Inc.
In a significant preliminary order, the UPC Local Division Hamburg rejected the request by Tandem Diabetes Care to stay an infringement action concerning its t:slim X2 insulin pump. The court emphasized the efficiency of the UPC system, stating that it is appropriate for the local division to hear both the infringement claim and the pending revocation actions simultaneously. This ruling reinforces the principle that procedural delays should not impede the pursuit of patent rights when a joint hearing can ensure a uniform legal outcome.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.